{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:27:27Z","timestamp":1793698047240,"version":"4.5.1"},"reference-count":39,"publisher":"The Journal of Rheumatology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2026,6,3]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Identifying patient characteristics that predict treatment response in psoriatic arthritis (PsA) may help optimize treat-to-target strategies. We aimed to explore overall and sex-specific predictors of secukinumab (SEC) effectiveness in European patients with PsA treated in routine care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from 14 registries in the European Spondyloarthritis (EuroSpA) Research Collaboration. Patients aged \u2265 18 years at diagnosis, initiating SEC treatment from January 2015 to January 2021, were included. Multiple imputation was used for missing covariates at treatment start (baseline) and Disease Activity Index for Psoriatic Arthritis based on 28 joints (DAPSA28) at 6 months. Overall and sex-stratified analyses were performed by logistic and Cox regressions to identify baseline predictors of the following treatment outcomes: (1) DAPSA28 low disease activity (LDA; DAPSA28 \u2264 14) at 6 months, (2) DAPSA28 moderate response at 6 months, and (3) SEC discontinuation within 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 2790 patients (43% male) were included. Median age was 43 years (IQR 34-52), and SEC was the first-line biologic\/targeted synthetic disease-modifying antirheumatic drug (b\/tsDMARD) in 665 patients (24%). Positive predictors for both DAPSA28 LDA and DAPSA28 moderate response were male sex, fewer previous b\/tsDMARDs, C-reactive protein (CRP) &gt; 10 mg\/L, and lower Health Assessment Questionnaire (HAQ) score. Absence of psoriasis, higher patient fatigue, and tender joint counts predicted SEC discontinuation within 12 months. For some outcomes, sex-specific predictors were fewer previous b\/tsDMARDs and CRP &gt; 10 mg\/L among male patients and lower patient fatigue score among female patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We identified overall and sex-specific predictors of SEC effectiveness in European patients with PsA. Our findings may support personalized treatment decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-1023","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:20:20Z","timestamp":1781526020000},"page":"977-985","source":"Crossref","is-referenced-by-count":0,"title":["Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-9235","authenticated-orcid":false,"given":"Jette","family":"Heberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-9457","authenticated-orcid":false,"given":"Stylianos","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7675-4844","authenticated-orcid":false,"given":"Zohra Faizy","family":"Ahmadzay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-8482","authenticated-orcid":false,"given":"Bente","family":"Glintborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1811-2417","authenticated-orcid":false,"given":"Isabel","family":"Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4085-0806","authenticated-orcid":false,"given":"Mehrdad Shoae","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6374-841X","authenticated-orcid":false,"given":"Anne Gitte","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-2840","authenticated-orcid":false,"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-277X","authenticated-orcid":false,"given":"Simon Horskj\u00e6r","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Laas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0248-6026","authenticated-orcid":false,"given":"Sigrid","family":"Vorobjov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1189-2380","authenticated-orcid":false,"given":"Fernando","family":"S\u00e1nchez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-9189","authenticated-orcid":false,"given":"Ziga","family":"Rotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-4016","authenticated-orcid":false,"given":"Katja Perdan","family":"Pirkmajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-7312","authenticated-orcid":false,"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-6505","authenticated-orcid":false,"given":"Bjorn","family":"Gudbjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6751-3330","authenticated-orcid":false,"given":"Gerdur","family":"Gr\u00f6ndal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-9946","authenticated-orcid":false,"given":"Catalin","family":"Codreanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-5344","authenticated-orcid":false,"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-235X","authenticated-orcid":false,"given":"He\u0159man","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3661-6072","authenticated-orcid":false,"given":"Dan","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5448-5080","authenticated-orcid":false,"given":"Anna-Mari","family":"Hokkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Barcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3894-5371","authenticated-orcid":false,"given":"Pawel","family":"Mielnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore K.","family":"Kvien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-1369","authenticated-orcid":false,"given":"Gokce","family":"Kenar-Artin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-1764","authenticated-orcid":false,"given":"Michael J.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-6167","authenticated-orcid":false,"given":"Burkhard","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9919-4487","authenticated-orcid":false,"given":"Tor","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4915-2924","authenticated-orcid":false,"given":"Johan K.","family":"Wallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-6818","authenticated-orcid":false,"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-467X","authenticated-orcid":false,"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-6831","authenticated-orcid":false,"given":"Lykke Midtb\u00f8ll","family":"\u00d8rnbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2026110300451237000_53.9.977.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557"},{"key":"2026110300451237000_53.9.977.2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41584-022-00810-7","article-title":"Sex- and gender-related differences in psoriatic arthritis","volume":"18","author":"Tarannum","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2026110300451237000_53.9.977.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2019.07.001"},{"key":"2026110300451237000_53.9.977.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211734"},{"key":"2026110300451237000_53.9.977.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225531"},{"key":"2026110300451237000_53.9.977.6","doi-asserted-by":"crossref","first-page":"105824","DOI":"10.1016\/j.jbspin.2024.105824","article-title":"Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis","volume":"92","author":"Pons","year":"2025","journal-title":"Jt Bone Spine"},{"key":"2026110300451237000_53.9.977.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209730"},{"key":"2026110300451237000_53.9.977.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex301"},{"key":"2026110300451237000_53.9.977.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.30117"},{"key":"2026110300451237000_53.9.977.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171034"},{"key":"2026110300451237000_53.9.977.11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/rheumatology\/kead284","article-title":"Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries","volume":"63","author":"Linde","year":"2024","journal-title":"Rheumatology"},{"key":"2026110300451237000_53.9.977.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151404"},{"key":"2026110300451237000_53.9.977.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170449"},{"key":"2026110300451237000_53.9.977.14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150805"},{"key":"2026110300451237000_53.9.977.15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/acr.25396","article-title":"Comparing DAPSA, DAPSA28 and DAS28-CRP in patients with psoriatic arthritis initiating a first tumor necrosis factor inhibitor across nine European countries","volume":"76","author":"Linde","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2026110300451237000_53.9.977.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110763"},{"key":"2026110300451237000_53.9.977.17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4081\/reumatismo.2020.1266","article-title":"Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12\/23 and IL-17 inhibitors. A multicenter prospective study","volume":"72","author":"Perrotta","year":"2020","journal-title":"Reumatismo"},{"key":"2026110300451237000_53.9.977.18","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001519"},{"key":"2026110300451237000_53.9.977.19","doi-asserted-by":"crossref","first-page":"e0002303","DOI":"10.1136\/rmdopen-2022-002303","article-title":"Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial","volume":"8","author":"Baraliakos","year":"2022","journal-title":"RMD Open"},{"key":"2026110300451237000_53.9.977.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42358-023-00295-2","article-title":"Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort","volume":"63","author":"Molica Colella","year":"2023","journal-title":"Adv Rheumatol"},{"key":"2026110300451237000_53.9.977.21","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03184-7"},{"key":"2026110300451237000_53.9.977.22","first-page":"8","article-title":"Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey","volume":"8","author":"Ahmadzay","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"2026110300451237000_53.9.977.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213463"},{"key":"2026110300451237000_53.9.977.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207507"},{"key":"2026110300451237000_53.9.977.25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/annrheumdis-2018-eular.3546","article-title":"AB0942 Concordance between fatigue, pain and patient global assessment in individual patients with psoriatic arthritis","volume":"77","author":"Madsen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026110300451237000_53.9.977.26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221477"},{"key":"2026110300451237000_53.9.977.27","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0473-3-17"},{"key":"2026110300451237000_53.9.977.28","doi-asserted-by":"crossref","unstructured":"Hosmer DW , Lemeshow S , May S. Applied survival analysis: regression modeling of time-to-event data. Chichester: John Wiley & Sons; 2008.","DOI":"10.1002\/9780470258019"},{"key":"2026110300451237000_53.9.977.29","unstructured":"International Monetary Fund . GDP per capita, current prices. [Internet. Accessed June 19, 2026.] Available from: https:\/\/www.imf.org\/external\/datamapper\/PPPPC@WEO\/CZE\/DNK\/EST\/FIN\/ISL\/ITA\/NLD\/NOR\/PRT\/ROU\/SVN\/ESP\/SWE\/CHE\/TUR\/GBR"},{"key":"2026110300451237000_53.9.977.30","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3177"},{"key":"2026110300451237000_53.9.977.31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4"},{"key":"2026110300451237000_53.9.977.32","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0105-z"},{"key":"2026110300451237000_53.9.977.33","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3994"},{"key":"2026110300451237000_53.9.977.34","unstructured":"R Core Team ; 2022. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing."},{"key":"2026110300451237000_53.9.977.35","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1016\/S2665-9913(23)00264-3","article-title":"Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis","volume":"5","author":"Eder","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026110300451237000_53.9.977.36","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00215-6"},{"key":"2026110300451237000_53.9.977.37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181089"},{"key":"2026110300451237000_53.9.977.38","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"339","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"2026110300451237000_53.9.977.39","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_543_18"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-1023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:46:17Z","timestamp":1793695577000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-1023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.3899\/jrheum.2025-1023"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-1023","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}